Join to View Full Profile
3855 Health Sciences Dr. #0819La Jolla, CA 92093
Phone+1 858-822-6346
Fax+1 858-732-0860
Dr. Piccioni is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Neuro-Oncology, 2009 - 2012- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2006 - 2009
University at BuffaloInternship, Internal Medicine, 2005 - 2006- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2005
Certifications & Licensure
CA State Medical License 2007 - 2025
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- A Phase II Study of Dacomitinib in Progressive Brain Metastases Start of enrollment: 2014 Feb 01
- Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma Start of enrollment: 2014 Feb 01
Publications & Presentations
PubMed
- Phase II trial of blood-brain barrier permeable peptide-paclitaxel conjugate ANG1005 in patients with recurrent high-grade glioma.Crismita Dmello, Andrew Brenner, David Piccioni, Patrick Y Wen, Jan Drappatz
Neuro-Oncology Advances. 2024-12-14 - Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma.Michael J Dennis, Dean C Pavlick, Alec Kacew, Michael Wotman, Laura E MacConaill
Journal of Translational Medicine. 2024-10-22 - 1 citationsDeep Learning Segmentation of Infiltrative and Enhancing Cellular Tumor at Pre- and Posttreatment Multishell Diffusion MRI of Glioblastoma.Louis Gagnon, Diviya Gupta, George Mastorakos, Nathan White, Vanessa Goodwill
Radiology. Artificial Intelligence. 2024-09-01
Press Mentions
Ivy Brain Tumor Center Expands Global Phase 3 Gliofocus Study to the EU and Additional U.S. StatesJanuary 15th, 2025- Northwest Biotherapeutics: Data Is Done, Just Wait for ApprovalNovember 23rd, 2022
- CIRM Awards $11.8 Million Grant for Clinical Trial in High-Grade Glioma Including Glioblastoma Using DB107, a Novel DGM7™ Genetic Biomarker-Guided Gene TherapyMay 1st, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
